TearSolutions
PrivateLast Round
Series B
Nov 21, 2024
Total Funding Raised
$14.5M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
TearSolutions operates in Healthcare & Life Sciences and is based in Charlottesville, Virginia. Its latest recorded funding round was a Series B round in November 2024.
TearSolutions is a biotechnology company that develops topical therapeutics for the treatment of dry eye disease.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Hardware Sales, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
TearSolutions Comparables
Compare TearSolutions with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Stuart Therapeutics, Inc. | 85% | |
| Claris Bio | 80% | |
| RegeneRx Biopharmaceuticals, Inc. | 79% |
For institutional investors. Book with your work email.
TearSolutions Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Nov 21, 2024 | ||||
| Series B | Dec 7, 2017 | ||||
| Series A | Nov 4, 2015 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
TearSolutions Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Virginia Innovation Partnership Corporation | Series A |
| Pharmstandard International S.A. | Series B |
| Launch Capital | Series A |
| Santen Ventures | Series B |
| VTC Ventures | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors increased 52% MoM.
- May 16, 2026
Monthly visitors increased 31% MoM.
For institutional investors. Book with your work email.
TearSolutions Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about TearSolutions's valuation, stock price, and market status.
Is TearSolutions a public or private company?
TearSolutions is a private company.
What is the current stock price of TearSolutions?
TearSolutions is a private company, so its shares have no public market price. Caplight tracks TearSolutions's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is TearSolutions worth (valuation)?
Valuation information for TearSolutions is not publicly available.
Can I buy TearSolutions stock?
TearSolutions shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was TearSolutions's last funding round?
TearSolutions's most recent funding round was Series B on November 21, 2024.
Who are the main investors in TearSolutions?
Key investors in TearSolutions include Virginia Innovation Partnership Corporation, Pharmstandard International S.A., Launch Capital, VTC Ventures.
Will TearSolutions IPO soon?
No public IPO plans have been announced for TearSolutions.
How can I track TearSolutions secondary market activity?
Caplight tracks bids, offers, and trades in TearSolutions's shares on secondary markets.